Abstract

BackgroundThe optimal treatment strategy for women with newly diagnosed ovarian cancer has yet to be determined. Poly(ADP-ribose) polymerase (PARP) inhibitors have demonstrated substantial improvement in progression-free survival as monotherapy maintenance...

Full Text

Published Version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
“You’ve got to know when to hold ‘em, know when to fold ‘em”: ovarian cancer risk reduction in patients with endometriosis
Phillip A Romanski ... Steven R Lindheim
Fertility and Sterility | VOL. 117
Phillip A Romanski, et. al.Phillip A Romanski ... Steven R Lindheim
01 May 2022
Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999-2016: a retrospective study based on the Korean National Cancer Incidence Database.
Wonkyo Shin ... Young Joo Won
Journal of Gynecologic Oncology | VOL. 31
Wonkyo Shin, et. al.Wonkyo Shin ... Young Joo Won
01 Jan 2020
Abstract CT158: ATHENA (GOG-3020/ENGOT-ov45): a randomized, double-blind, placebo-controlled, Phase III study of rucaparib + nivolumab following front-line platinum-based chemotherapy in ovarian cancer
Shannon N Westin ...
Cancer Research | VOL. 79
Shannon N Westin, et. al.Shannon N Westin ...
01 Jul 2019
Ovarian Cancer Risk Factor Associations by Primary Anatomic Site: The Ovarian Cancer Cohort Consortium.
Renée T Fortner ...
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology | VOL. 29
Renée T Fortner, et. al.Renée T Fortner ...
01 Oct 2020
View more papers

More From: International Journal of Gynecologic Cancer

Paper Title
Journal
Date
Author
Correction: Extra-cranial meningioma associated with relapse of immature ovarian teratoma
-
International Journal of Gynecologic Cancer | VOL. 34
--
01 Dec 2024
Spontaneously ruptured endometrioma masquerading as ovarian malignancy
Shagun Kapoor ... Seema Singhal
International Journal of Gynecologic Cancer | VOL. 34
Shagun Kapoor, et. al.Shagun Kapoor ... Seema Singhal
01 Dec 2024
Challenges in differentiating between primary cervical cancer versus stage II endometrial cancer
Vanessa Alvarenga-Bezerra ... Pedro T Ramirez
International Journal of Gynecologic Cancer | VOL. 34
Vanessa Alvarenga-Bezerra, et. al.Vanessa Alvarenga-Bezerra ... Pedro T Ramirez
01 Dec 2024
Uterine inflammatory myofibroblastic tumor with myxoid predominance: diagnostic challenge
Miguel Rodrigues ... Catarina Ivanova
International Journal of Gynecologic Cancer | VOL. 34
Miguel Rodrigues, et. al.Miguel Rodrigues ... Catarina Ivanova
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.